HDAC6 Inhibitors Sensitize Non-Mesenchymal Triple-Negative Breast Cancer Cells to Cysteine Deprivation

To overcome cysteine deprivation resistance in TNBC cells, scientists identified three selective HDAC6 inhibitors using epigenetic compound library screening and used them to induce cell death in the non-mesenchymal TNBC.